Children's Hospital of Eastern Ontario, Ottawa
POGO Lecture Series 2011/2012
Wednesday, February 15, 2012
Dr. James A. Whitlock -Pediatric Grand Rounds, Children’s Hospital of Eastern Ontario
Time: 8:30 – 9:30 a.m.
Topic: Down Syndrome and Cancer
Wednesday, February 15, 2012
Dr. James A. Whitlock - Hematology Oncology Fellow Academic Half Day, Children’s Hospital of Eastern Ontario
Time: 1:00 – 4:00 p.m.
Topic: Relapsed ALL
Thursday, February 16, 2012
Dr. James A. Whitlock - Pediatric Resident Academic Half Day, Children’s Hospital of Eastern Ontario
Time: 3:00 – 4:30 p.m.
Topic: Langerhans Cell Histiocytosis
For more details on these presentations, click here.
Speaker Information:
James A. Whitlock, M.D.
Dr. James A. Whitlock is the Division Head and Women’s Auxiliary Millennium Chair in Haematology/Oncology at The Hospital for Sick Children, a Senior Associate Scientist in the Child Health Evaluative Sciences Program at SickKids Research Institute, and Professor of Paediatrics at the University of Toronto.
Dr. Whitlock’s research interests include the biology and treatment of childhood acute leukemias, the development of new drugs for the treatment of childhood cancers, the biology and treatment of childhood cancers in Down syndrome, and the biology and treatment of histiocytic disorders. He has authored or co-authored over 80 peer-reviewed and invited manuscripts and book chapters. He serves as the Vice-Chair for New Agents and Relapse studies for the Acute Lymphoblastic Leukemia Committee of the Children’s Oncology Group, and has been Chair or Vice-Chair of several national clinical trials for the Children’s Cancer Group and the Children’s Oncology Group. He is the lead investigator for an international trial for relapsed T-cell ALL through the Therapeutic Advances in Childhood Leukemia (TACL) consortium, and serves as chair of TACL’s Steering & Prioritization Committee. He is a founding investigator of the Pediatric Oncology Experimental Therapeutics Investigators’ Consortium (POETIC) and a member of its Board of Directors. He is the current President of the Histiocyte Society and a member of the Board of Directors of the Histiocytosis Association of America.
For more information on this event, please contact:
Darlene Myers-Savard
Senior Administrative Assistant
Department of Pediatrics, Hematology Oncology Division
Children’s Hospital of Eastern Ontario
Email: dmyerssavard@cheo.on.ca
Phone: (613) 737-7600 Ext 2370
